Apr. 21 at 2:02 PM
$DHR — Danaher new investor settlement just reached
Terms still being finalized, but you can apply now and get in the queue.
📌 What happened?
In early 2022, Danaher told investors its bioprocessing business would keep growing even as COVID demand eased. What they allegedly didn't say: large pharma customers were sitting on pandemic inventory and not reordering, while small biotechs were cutting projects as funding dried up.
Then came the guidance cut parade:
Jul 2022: COVID rev cut to ~
$1B
Oct 2022: Cut again to ~
$800M →
$DHR −6%
Jan 2023: 2023 outlook slashed to ~
$150M →
$DHR −5.2%
Apr 2023: Base business cut too →
$DHR −9%+
Settlement reached Mar 2026.
❓ Who qualifies?
Buyers of
$DHR between 1/27/2022–10/23/2023.
➡️ Apply now:
11th.com/cases/danaher-investor-settlement
